Search Results 51-60 of 19367 for autoimmune hepatitis
Many people with this infection don't know they have it. Find out about symptoms and treatment for this liver disease that can be dangerous.
The purpose of this study aims to investigate the efficacy and safety of survodutide administered once weekly vs. placebo on liver-related outcome events and ...
... liver disease, Liver problems..., Primary sclerosing cholangitis, Portal hypertension, Hemochromatosis, Autoimmune hepatitis, Wilson's disease, Hepatitis ...
Your immune system is weakened by medicine or illness. Treatment helps lower the risk of liver disease and prevents you from passing the infection to others.
The purpose of this study is to determine if Non-Alcoholic Fatty Liver Disease (NAFLD) patients with advanced fibrosis will demonstrate a change in PRO-C3, a ...
Mayo Clinic's Data Analytics and AI for Advanced Liver Disease Lab seeks to develop AI algorithms to improve care of patients with liver diseases.
Specialized treatment for patients with immune-mediated liver disease, such as primary biliary cirrhosis, autoimmune hepatitis and primary sclerosing ...
Autoimmune hepatitis (liver inflammation) or; Human immunodeficiency virus (HIV) infection or; Kidney disease, severe or; Liver or other organ transplant or ...
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world. Learn more from Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.